Spyros Papapetropoulos's Net Worth
$47.8 Thousand
Who is Spyros Papapetropoulos?
Spyros Papapetropoulos does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Lipocine Inc., Vigil Neuroscience, Inc., and Adamas Pharmaceuticals Inc.
SEC CIK
Spyros Papapetropoulos's CIK is 0001832694
Past Insider Trading and Trends
2022 was Spyros Papapetropoulos's most active year for acquiring shares with 6 total transactions. Spyros Papapetropoulos's most active month to acquire stocks was the month of October. 2021 was Spyros Papapetropoulos's most active year for disposing of shares, totalling 3 transactions. Spyros Papapetropoulos's most active month to dispose stocks was the month of October. 2021 saw Spyros Papapetropoulos paying a total of $30,233.50 for 20,975 shares, this is the most they've acquired in one year. In 2022 Spyros Papapetropoulos cashed out on 600 shares for a total of $4,200.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Lipocine Inc. (LPCN) Snapshot price: $3.995
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 10
| |||
Form 4
|
∞
| 21.74K |
$0.47 | $10,217.33 | 21.74K |
Nov 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Vigil Neuroscience, Inc. (VIGL) Snapshot price: $2.85
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$7.95 | -$3,633.00 | 4K |
Scheduled
|
Nov 18
| ||
Form 4
|
∞
| 4K |
$3.40 | $13,591.20 | 4K |
May 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Adamas Pharmaceuticals Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -20.98K |
—
|
—
|
0
|
Nov 24
| |||
Form 4
| +31.30% | 5K |
—
|
—
| 20.98K |
Jun 2
| |||
Form 4
| +59.75% | 5.97K |
$5.06 | $30,233.50 | 15.97K |
Mar 11
| |||
Form 4
|
∞
| 10K |
—
|
—
| 10K |
Nov 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BIONOMICS LIMITED/FI (BNOX) No price found
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||